YEREVAN, NOVEMBER 17, NOYAN TAPAN. A rise in the sale prices of several medicines has been recorded as a result of the checks conducted by the RA State Commission for the Protection of Economic Competition in October-November of this year. According to the preliminary study of the Commission's experts, the behavior of the big economic entities engaged in the import and sale on the markets of cardiovascular, anti-virus and diabetic medicines may bear evidence of possible violations of the legislation on competition. For that reason, at the November 17 sitting, the Commission initiated legal proceedings in the indicated markets. During the proceedings, the compliance of the behavior of the following entities with competition rules will be examined. These economic entities are: Esculap LLC, Argo Pharm LLC, Asteria LLC, Alpha Pharm CJSC, Natali Pharm LLC, Vaga Pharm LLC, Arpimed CJSC, Arpharmatsia CJSC, Amikus LLC, Lagi LLC, Deghabaza Yerevan LLC, Rus Pharm LLC, Richter Lambron LLC, Tonus Les LLC, Pharm Gohar LLC, Asteria LLC, Pharm Trust LLC, and Orient Pharm LLC (these economic entities are the biggest ones in the market). At the Commission's sitting, the economic entities were asked to provide information about the components of the structure of the purchase prices of goods and their sale prices, also the reasons for a change in prices. They were also asked to present copies of the agreements and invoices. The list of the medicines of social importance, whose prices have been raised in an unfounded way (in the preliminary opinion of experts) will be available on www.competition.am website.

---